Related Experiment Video
Updated: Mar 31, 2026

Fast and Specific Assessment of the Halogenating Peroxidase Activity in Leukocyte-enriched Blood Samples
Published on: July 28, 2016
Thioxo-dihydroquinazolin-one Compounds as Novel Inhibitors of Myeloperoxidase
Yang Li1, Thota Ganesh2, Becky A Diebold1
1Department of Pathology and Laboratory Medicine, Emory University , Atlanta, Georgia 30322, United States.
Abstract:
Myeloperoxidase (MPO) is a key antimicrobial enzyme, playing a normal role in host defense, but also contributing to inflammatory conditions including neuroinflammatory diseases such as Parkinson's and Alzheimer's. We synthesized and characterized more than 50 quinazolin-4(1H)-one derivatives and showed that this class of compounds inhibits MPO with IC50 values as low as 100 nM. Representative compounds showed partially reversible inhibition that was competitive with respect to Amplex Red substrate and did not result in the accumulation of MPO Compound II. Members of this group show promise for therapeutic development for the treatment of diseases in which inflammation plays a pathogenic role.
Insights
Researchers developed novel quinazolin-4(1H)-one compounds that effectively inhibit myeloperoxidase (MPO), an enzyme implicated in inflammatory and neurodegenerative diseases like Parkinson's and Alzheimer's.
Area of Science:
- Biochemistry
- Medicinal Chemistry
- Neuroscience
Background:
- Myeloperoxidase (MPO) is an enzyme crucial for host defense but also implicated in inflammatory processes.
- MPO activity is linked to the pathogenesis of neuroinflammatory diseases, including Parkinson's and Alzheimer's disease.
Purpose of the Study:
- To synthesize and characterize novel quinazolin-4(1H)-one derivatives as potential inhibitors of MPO.
- To evaluate the inhibitory potential of these compounds against MPO for therapeutic applications.
Main Methods:
- Synthesis and characterization of over 50 quinazolin-4(1H)-one derivatives.
- Enzyme inhibition assays to determine IC50 values and mechanism of inhibition (e.g., substrate competition).
Main Results:
- Over 50 quinazolin-4(1H)-one derivatives were synthesized and characterized.
- Compounds demonstrated potent MPO inhibition with IC50 values down to 100 nM.
- Inhibition was partially reversible and competitive with respect to Amplex Red, without Compound II accumulation.
Conclusions:
- Quinazolin-4(1H)-one derivatives represent a promising class of MPO inhibitors.
- These compounds hold potential for therapeutic development in diseases driven by MPO-mediated inflammation.
Related Concept Videos
Oxidation of Phenols to Quinones
o-hydroxy phenols are oxidized to o-quinones and p-hydroxy phenols to p-quinones. Such redox reactions involve the transfer of two electrons and two protons. The reversible redox...
The Electron Transport Chain
Inhibitors of the electron transport chain
Rotenone, a widely used pesticide, prevents electron transfer from Fe-S cluster to ubiquinone or Q...
Gene Regulation in Microbial Communities: Quorum Sensing
Enzyme Inhibition
Inhibitors of Bacterial DNA Synthesis
Peroxisomes

